According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold 395,617 shares of CRISPR Therapeutics AG during the third quarter. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback